Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Daratumumab, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03841565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07333430. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma
ClinicalTrials.gov study NCT01617213. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07312188. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma
ClinicalTrials.gov study NCT02897830. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05651932. IPD Sharing: UNDECIDED. Countries: 4. Publications: 0.
Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05007418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03763162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01330173. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan
ClinicalTrials.gov study NCT05286229. IPD Sharing: NO. Countries: 1. Publications: 0.
Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure
ClinicalTrials.gov study NCT00062621. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Dose Escalation Study of the Combination of Lenalidomide (Revlimid®), Dexamethasone and Cyclophosphamide in Patients Refractory or Relapsing From Stable Disease With Multiple Myeloma
ClinicalTrials.gov study NCT00915408. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment
ClinicalTrials.gov study NCT07376720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
ClinicalTrials.gov study NCT04287660. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With High-Risk Multiple Myeloma
ClinicalTrials.gov study NCT03756896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple Myeloma
ClinicalTrials.gov study NCT06170151. IPD Sharing: NO. Countries: 1. Publications: 0.
Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT03200626. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT00609817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT02624440. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
ClinicalTrials.gov study NCT02833610. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.